Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
By studying individual biomarkers in body fluids such as saliva, there is a potential for detecting injury to the brain resulting from an acute traumatic even that may not be detectable by conventional neuroimaging like CT scans.
Although identification of biomarkers following TBI is a rather novel area of research, few studies that have been done in patients with severe TBI and biomarkers from serum and cerebrospinal fluid have shown to have prognostic significance. However there are no prior studies looking at biomarkers in salivary specimens. In this study we will include patients with moderate and severe TBI who require inpatient admission, and will study 3 specific salivary biomarkers. This is a unique project, since salivary specimen collection is easy and non-invasive and can be collected at any site even on a sports field by using a simple absorbable swab resembling a cigarette stub, unlike blood or CSF that can be highly invasive. Salivary specimens can also be frozen and stored for long periods of time prior to testing. If our study detects abnormalities in levels of these biomarkers when compared to healthy controls, and children with extra-cerebral injuries, in future studies we can look at children and adolescents with minor head traumas and concussions who are discharged from the emergency department after evaluation, and study their long-term outcomes and correlation with salivary biomarkers.
Specific aims:
To study levels of three specific biomarkers in salivary specimens (GFAP, S100B and NSE) in children with moderate TBI (GCS: 9-12) and severe TBI (GCS: <8) admitted to a pediatric trauma referral center. These biomarkers have been shown to have prognostic significance in prior studies using serum and CSF.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control Group 1 | Children with non-trauma complaints | ||
| Control Group 2 | Children with non TBI and musculoskeletal trauma | ||
| Cases | Children admitted to hospital with moderate/severe isolatedTBI |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Levels of 3 specific salivary biomarkers (GFAP, S100B, and NSE) | Within 24 hours of an acute isolated TBI | Within 24 hours of injury |
| Measure | Description | Time Frame |
|---|---|---|
| Glasgow Coma Scale measurement of injury severity | Glasgow Coma Scale is a score between 3 and 15, 3 being the worst, and 15 the best. It is composed of three parameters: Best Eye Response, Best Verbal Response, and Best Motor Response. A Coma Score of 13 or higher correlates with a mild brain injury, 9 to 12 is a moderate injury and 8 or less a severe brain injury. | Day 1 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
1) Children aged 0 to 20 who present to the pediatric ED or trauma bay with an isolated acute head injury (moderate or severe) and are admitted for inpatient management; 2) pediatric patients who present to the ED with non-trauma complaints; and 3) pediatric patients who present to the ED with non-head trauma such as musculoskeletal injuries.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Claudia Yeung, MD | Valleywise Health | Study Director |
| Kevin Foster, MD | Valleywise Health | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Maricopa Integrated Health System | Phoenix | Arizona | 85008 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 23399646 | Background | Zetterberg H, Smith DH, Blennow K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol. 2013 Apr;9(4):201-10. doi: 10.1038/nrneurol.2013.9. Epub 2013 Feb 12. | |
| 21524681 | Background | Olsson B, Zetterberg H, Hampel H, Blennow K. Biomarker-based dissection of neurodegenerative diseases. Prog Neurobiol. 2011 Dec;95(4):520-34. doi: 10.1016/j.pneurobio.2011.04.006. Epub 2011 Apr 16. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000070642 | Brain Injuries, Traumatic |
| D006259 | Craniocerebral Trauma |
| ID | Term |
|---|---|
| D001930 | Brain Injuries |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Salivary biomarkers: S100B, neuron-specific enolase, GFAP
| Brain CT Scan abnormalities suggesting significant brain injury | Dichotomous measure: presence or absence of such abnormalities | Within 24 hours of injury |
| Need for mechanical ventilation | Mechanical ventilators are used for patients who cannot breathe by themselves. Dichotomous measure: whether or not mechanical ventilation is needed. | During hospitalization (up to 50 days) |
| Need for neurosurgical intervention including ICP monitor | Dichotomous measure: whether or not neurosurgical intervention is needed | During hospitalization (up to 50 days) |
| Patient's Length of Stay or hospitalization | Number of days spent in hospital | Duration of hospitalization (up to 50 days) |
| Final disposition | Polytomous measure: Discharge to home, discharge to rehab, or death | At end of hospitalization (up to 50 days) |
| Background | Faul M, Xu L, Wald MM, Coronado V. Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths, 2002--2006. Atlanta, GA: CDC, National Center for Injury Prevention and Control; 2010. |
| D020196 |
| Trauma, Nervous System |
| D014947 | Wounds and Injuries |